CROSS COUNTRY HEALTHCARE INC (CCRN)
US2274831047 - Common Stock
Overall CCRN gets a fundamental rating of 6 out of 10. We evaluated CCRN against 118 industry peers in the Health Care Providers & Services industry. CCRN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CCRN has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
CCRN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 10.68%, CCRN belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.32%, CCRN belongs to the top of the industry, outperforming 85.34% of the companies in the same industry.
The Return On Invested Capital of CCRN (15.89%) is better than 93.97% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCRN is significantly above the industry average of 8.58%.
The 3 year average ROIC (21.83%) for CCRN is well above the current ROIC(15.89%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.68% | ||
| ROE | 15.32% | ||
| ROIC | 15.89% |
ROA(3y)16.2%
ROA(5y)5.97%
ROE(3y)33.65%
ROE(5y)11.41%
ROIC(3y)21.83%
ROIC(5y)14.11%
1.3 Margins
The Profit Margin of CCRN (3.59%) is better than 77.59% of its industry peers.
With a decent Operating Margin value of 5.80%, CCRN is doing good in the industry, outperforming 71.55% of the companies in the same industry.
CCRN's Operating Margin has improved in the last couple of years.
CCRN's Gross Margin of 22.30% is in line compared to the rest of the industry. CCRN outperforms 44.83% of its industry peers.
CCRN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.8% | ||
| PM (TTM) | 3.59% | ||
| GM | 22.3% |
OM growth 3Y54.33%
OM growth 5Y25.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y-2.78%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CCRN is creating value.
CCRN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 6.20 indicates that CCRN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.20, CCRN belongs to the best of the industry, outperforming 92.24% of the companies in the same industry.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.2 |
ROIC/WACC1.77
WACC9%
2.3 Liquidity
A Current Ratio of 2.79 indicates that CCRN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.79, CCRN belongs to the top of the industry, outperforming 83.62% of the companies in the same industry.
CCRN has a Quick Ratio of 2.79. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.79, CCRN belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.79 | ||
| Quick Ratio | 2.79 |
3. Growth
3.1 Past
The earnings per share for CCRN have decreased strongly by -57.98% in the last year.
Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 76.23% on average per year.
The Revenue for CCRN has decreased by -28.04% in the past year. This is quite bad
Measured over the past years, CCRN shows a quite strong growth in Revenue. The Revenue has been growing by 19.86% on average per year.
EPS 1Y (TTM)-57.98%
EPS 3Y68.74%
EPS 5Y76.23%
EPS growth Q2Q-73.39%
Revenue 1Y (TTM)-28.04%
Revenue growth 3Y34.16%
Revenue growth 5Y19.86%
Revenue growth Q2Q-34.09%
3.2 Future
Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.33% on average per year.
CCRN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.75% yearly.
EPS Next Y-56.9%
EPS Next 2Y-24.92%
EPS Next 3Y-12.33%
EPS Next 5YN/A
Revenue Next Year-26.2%
Revenue Next 2Y-12.4%
Revenue Next 3Y-6.75%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.54, the valuation of CCRN can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CCRN indicates a rather cheap valuation: CCRN is cheaper than 94.83% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CCRN to the average of the S&P500 Index (28.28), we can say CCRN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 17.50, the valuation of CCRN can be described as rather expensive.
71.55% of the companies in the same industry are more expensive than CCRN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.88, CCRN is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.54 | ||
| Fwd PE | 17.5 |
4.2 Price Multiples
99.14% of the companies in the same industry are more expensive than CCRN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCRN is valued cheaply inside the industry as 98.28% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.47 | ||
| EV/EBITDA | 4.16 |
4.3 Compensation for Growth
The decent profitability rating of CCRN may justify a higher PE ratio.
CCRN's earnings are expected to decrease with -12.33% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-24.92%
EPS Next 3Y-12.33%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CROSS COUNTRY HEALTHCARE INC
NASDAQ:CCRN (5/3/2024, 7:00:02 PM)
After market: 16.67 0 (0%)16.67
-0.07 (-0.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap578.12M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.54 | ||
| Fwd PE | 17.5 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.68% | ||
| ROE | 15.32% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 5.8% | ||
| PM (TTM) | 3.59% | ||
| GM | 22.3% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.79 | ||
| Quick Ratio | 2.79 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-57.98%
EPS 3Y68.74%
EPS 5Y
EPS growth Q2Q
EPS Next Y-56.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-28.04%
Revenue growth 3Y34.16%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y